Clinical trial achieved all three primary objectives with no significant safety issues being reported Results indicate that Emrosi can be safely used for up to 16 weeks with no detectable impact on ...
Driven by a dual product strategy of "digestion + gynecology," Wedge Pharma has established differentiated market barriers and is gradually building a product matrix that spans the entire lifecycle of ...
Integrated isolators, sterilization technologies, and filling solutions deliver proven sterility, reliability, and efficiency ...
The Global Pharmaceutical Bags Aseptic Filling Market is growing due to increasing demand for parenteral drugs, emphasis on ...
Technological advancements in synthetic chemistry, bioproduction, and containment are enhancing the feasibility of developing ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco(TM) Bacto(TM) CD Supreme FPM Plus and Gibco(TM) Bacto(TM) CD Supreme Feed (2X), two ...
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on developing innovative therapies for unmet needs, today announced that the U.S. Food and Drug Administration (FDA) has ...
Beyond Next Ventures backed Biomoneta bags US FDA approval for air-decontamination medical device: Our Bureau, Bengaluru Tuesday, December 2, 2025, 17:20 Hrs [IST] Biomoneta, a pi ...
Dust in the food and beverage industry is much more than a housekeeping nuisance — it’s directly tied to food safety, product ...
Researchers have assembled the first telomere-to-telomere (T2T) gap-free genome of Platycodon grandiflorus, a traditional medicinal herb valued for ...
Biomoneta, a pioneering healthtech company building advanced air-decontamination technologies, announced that its flagship product Avata Rx, powered by its proprietary ZeBox microbicidal technology, h ...
Enabling Pivotal Phase 2/3 STEP Study in Epidermolysis BullosaPress release2025-12-09 09:28Helene Hartman, CEO of XinnateLund, Sweden – Xinnate is taking a major step toward reshaping the treatment ...